Oct 30, 2018
1:150
For every 150 shares held, investors received 1. The price per share adjusted from $0.05 to $0.00.
The split itself did not change the total investment value.
Bionik Laboratories Corp. (BNKL) trades on the Other OTC in the Medical - Care Facilities industry.
Bionik Laboratories Corp. company overviewThe latest split shown was on October 30, 2018. It was a 1-for-150 reverse split, so shareholders received 1 share for every 150 they held.
This history records one reverse split, on October 30, 2018.